ConductScience.org, home

Paper29348681

Impact of a five-dimensional framework on R&D productivity at AstraZeneca.

Morgan P and 16 others. Nat Rev Drug Discov, 2018. Cited by 294 papers, by iCite.

Cite this record

ConductScience Library. Impact of a five-dimensional framework on R&D productivity at AstraZeneca. Papers, record 29348681. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29348681

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of a five-dimensional framework on R&D productivity at AstraZeneca.
PubMed
Journal
Nat Rev Drug Discov
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
294
iCite
Relative citation ratio, by iCite
11.1
iCite
Revised in PubMed
2026-10-12
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morgan PPaul
2Brown DGDean G
3Lennard SSimon
4Anderton MJMark J
5Barrett JCJ Carl
6Eriksson UUlf
7Fidock MMark
8Hamrén BBengt
9Johnson AAnthony
10March RERuth E
11Matcham JJames
12Mettetal JJerome
13Nicholls DJDavid J
14Platz SStefan
15Rees SSteve
16Snowden MAMichael A
17Pangalos MNMenelas N

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomedical ResearchMajor topic
Decision Making, OrganizationalMajor topic
Drug IndustryMajor topic
Drugs, InvestigationalMajor topic
Efficiency, OrganizationalMajor topic
ResearchMajor topic
Research DesignMajor topic
Clinical Trials as Topic
Efficiency
Humans
Organizational Culture

Source PubMed

Download CSV of topics

References120

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125336761Existing and Emerging Technologies for Point-of-Care Testing.Clin Biochem Rev2014https://conductscience.org/library/papers/25336761PubMed
226457449How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets.J Med Chem2016https://conductscience.org/library/papers/26457449PubMed
327932801DNA-encoded chemistry: enabling the deeper sampling of chemical space.Nat Rev Drug Discov2017https://conductscience.org/library/papers/27932801PubMed
423449292European lead factory opens for business.Nat Rev Drug Discov2013https://conductscience.org/library/papers/23449292PubMed
527417848Reducing the risk of failure: biomarker-guided trial design.Nat Rev Drug Discov2016https://conductscience.org/library/papers/27417848PubMed
624448973Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24448973PubMed
725628072Factors influencing quality decision-making: regulatory and pharmaceutical industry perspectives.Pharmacoepidemiol Drug Saf2015https://conductscience.org/library/papers/25628072PubMed
821956170Workflow and metrics for image quality control in large-scale high-content screens.J Biomol Screen2012https://conductscience.org/library/papers/21956170PubMed
918336218Recent advances in high throughput screening for ADME properties.Comb Chem High Throughput Screen2008https://conductscience.org/library/papers/18336218PubMed
1025306557Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.Lancet Respir Med2014https://conductscience.org/library/papers/25306557PubMed
1124893891AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.Cancer Discov2014https://conductscience.org/library/papers/24893891PubMed
1228244990The chemical evolution of oligonucleotide therapies of clinical utility.Nat Biotechnol2017https://conductscience.org/library/papers/28244990PubMed
1327140035Secondary pharmacology: screening and interpretation of off-target activities - focus on translation.Drug Discov Today2016https://conductscience.org/library/papers/27140035PubMed
1427913228PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.J Thorac Oncol2017https://conductscience.org/library/papers/27913228PubMed
1511927654IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells.J Leukoc Biol2002https://conductscience.org/library/papers/11927654PubMed
1627177493Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.Lancet Respir Med2016https://conductscience.org/library/papers/27177493PubMed
1723400000Development of PI3K inhibitors: lessons learned from early clinical trials.Nat Rev Clin Oncol2013https://conductscience.org/library/papers/23400000PubMed
1827435396Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity.Clin Cancer Res2016https://conductscience.org/library/papers/27435396PubMed
1927469033Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.Nat Rev Drug Discov2016https://conductscience.org/library/papers/27469033PubMed
2022697420The right compound in the right assay at the right time: an integrated discovery DMPK strategy.Drug Metab Rev2012https://conductscience.org/library/papers/22697420PubMed

See all 120 referencesDownload CSV of references

Cited by149

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 294 citations.

PMIDTitleJournalYearIn PapersSource
42943207Clinically Anchored GPCR Drug Discovery: Translational Lessons from Success, Failure, and Post-Approval Reassessment.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943207PubMed
42866684Persistent clinical attrition does not establish animal models as a root cause of drug-development failures.NAM J2026https://conductscience.org/library/papers/42866684PubMed
42855516Proteome-guided drug discovery maps and mitigates therapeutic degrader toxicity.Nat Chem Biol2026https://conductscience.org/library/papers/42855516PubMed
42835622
Six decades of evidence: biological factors predominate among reported reasons for clinical drug failure: A response to "Persistent clinical attrition does not establish animal models as a root cause of drug-development failures" by Peter MA Groenen.
NAM J2026https://conductscience.org/library/papers/42835622PubMed
42785112Evoke (+) trials of semaglutide for early alzheimer's disease: Innovations, lessons, and implications.J Prev Alzheimers Dis2026https://conductscience.org/library/papers/42785112PubMed
42761162Integration of microphysiological systems with computational and digital twin modeling for pharmaceutical development: a systematic review.J Pharm Pharm Sci2026https://conductscience.org/library/papers/42761162PubMed
42702743The Governance Gap: Democratizing Drug Development Through Decision Architecture.Clin Pharmacol Ther2026https://conductscience.org/library/papers/42702743PubMed
42665646Data-centric feedback loops for next-generation immunotherapy development.Nat Biomed Eng2026https://conductscience.org/library/papers/42665646PubMed
42630996Epidermal Growth Factor Receptor as a Model Drug Target for Scrutinizing the Status Quo in Drug Discovery and Chemical Biology.ACS Bio Med Chem Au2026https://conductscience.org/library/papers/42630996PubMed
42576973Need for NAMs: A systematic evidence synthesis revealing over half a century of drug development failure.NAM J2026https://conductscience.org/library/papers/42576973PubMed
42567977Artificial intelligence in drug discovery - what it is, where we stand and the path forward.Nat Rev Drug Discov2026https://conductscience.org/library/papers/42567977PubMed
42443933Translational assessment instruments for preclinical to first-in-human decision-making: a scoping review.J Transl Med2026https://conductscience.org/library/papers/42443933PubMed
4212519525 years of applying the 3Rs principles in safety pharmacology: success stories and future perspectives.Front Physiol2026https://conductscience.org/library/papers/42125195PubMed
42092189A network medicine framework for multi-modal data integration in therapeutic target discovery.Commun Chem2026https://conductscience.org/library/papers/42092189PubMed
42091774De-risking Biopharma Asset Acquisition: Towards a Quantitative Framework for Strategic Decision-making.AAPS J2026https://conductscience.org/library/papers/42091774PubMed
42023479Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42023479PubMed
41977224Mapping the Extended Pain Pathway: Human Genetic and Multi-Omic Strategies for Next-Generation Analgesics.Int J Mol Sci2026https://conductscience.org/library/papers/41977224PubMed
41970855Pharmacokinetic Prediction of Repurposed Drugs for PDAC Using Artificial Intelligence.ACS Omega2026https://conductscience.org/library/papers/41970855PubMed
41968138Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking system.Sci Rep2026https://conductscience.org/library/papers/41968138PubMed
41938843Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trial.EClinicalMedicine2026https://conductscience.org/library/papers/41938843PubMed

See all 149 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29348681

GET https://conductscience.org/api/papers/v1/29348681/references?page=2